查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032744

全球牙周治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Periodontal Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球牙周治療市場預計將從2025年的98.6億美元成長至2034年的156.6億美元，2026年至2034年的複合年成長率（CAGR）為5.27%。該市場正經歷穩定成長，主要原因是牙齦炎和牙周炎等牙周疾病的盛行率不斷上升。口腔衛生意識的提高以及對早期診斷和治療重要性的認知是推動市場需求的主要因素。此外，雷射療法、再生醫學和微創治療方法等先進治療方法的普及也進一步促進了市場擴張。

生活方式的改變、不健康的飲食習慣以及菸草製品消費量的增加，都會導致口腔健康問題，從而推動了該市場的成長。牙科診所的擴張和專業牙科服務可近性的提高也促進了市場成長。牙科設備和治療技術的進步正在改善患者的治療效果，並鼓勵更多人尋求治療。

未來，人們對預防性牙科和定期檢查的日益重視預計將對市場產生積極影響。治療方法和材料的創新將提高治療效果並縮短恢復時間。對美容牙科日益成長的需求以及發展中地區牙科保健服務可及性的提高也將推動市場進一步成長。隨著口腔衛生意識的不斷提高，牙周治療市場預計將穩定擴張。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點，或針對特定細分市場的深入洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球牙周治療市場：依治療類型分類

  • 市場分析、洞察與預測
  • 非手術治療
  • 手術治療

第5章 全球牙周治療市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 牙醫診所
  • 其他

第6章 全球牙周治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 對中東和非洲市場的分析、洞察和預測。
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Amyndas Pharmaceuticals
    • 3M
    • AMD Lasers Inc
    • ASA Dental SpA
    • Biolase Inc
    • Carl Martin GmbH
    • Danaher
    • Dentsply Sirona
    • Deppeler SA
    • Karl Schumacher
    • Medtronic
    • Novartis AG
    • Pfizer Inc
    • Planmeca Oy
簡介目錄
Product Code: VMR112110266

The global periodontal treatment market size is expected to reach USD 15.66 Billion in 2034 from USD 9.86 Billion in 2025, growing at a CAGR of 5.27 during 2026-2034.This market is experiencing steady growth due to the increasing prevalence of gum diseases such as gingivitis and periodontitis. Rising awareness about oral hygiene and the importance of early diagnosis and treatment are key factors driving demand. The availability of advanced treatment options, including laser therapy, regenerative procedures, and minimally invasive techniques, is further supporting market expansion.

The growth of this market is driven by changing lifestyles, unhealthy dietary habits, and the increasing consumption of tobacco products, all of which contribute to oral health issues. The expansion of dental clinics and the growing availability of specialized dental services are also boosting market growth. Technological advancements in dental equipment and treatment procedures are improving patient outcomes and encouraging more individuals to seek treatment.

In the future, the market is expected to benefit from increased focus on preventive dental care and regular check-ups. Innovations in treatment methods and materials will enhance effectiveness and reduce recovery time. Rising demand for cosmetic dentistry and improved access to dental care in developing regions will further support growth. As awareness about oral health continues to increase, the periodontal treatment market is expected to expand consistently.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Treatment Type

  • Non-Surgical Treatment
  • Surgical Treatment

By End-user

  • Hospitals
  • Dental Clinics
  • Others

COMPANIES PROFILED

  • Amyndas Pharmaceuticals, 3M, AMD Lasers Inc., ASA Dental S.p.A, Biolase Inc., Carl Martin GmbH, Danaher, Dentsply Sirona, Deppeler SA, Karl Schumacher, Medtronic, Novartis AG, Pfizer Inc., Planmeca Oy.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERIODONTAL TREATMENT MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Treatment Type
  • 4.2. Non-Surgical Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Surgical Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERIODONTAL TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-user
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Dental Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERIODONTAL TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Treatment Type
    • 6.2.2 By End-user
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Treatment Type
    • 6.3.2 By End-user
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Treatment Type
    • 6.4.2 By End-user
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Treatment Type
    • 6.5.2 By End-user
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Treatment Type
    • 6.6.2 By End-user
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PERIODONTAL TREATMENT INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Amyndas Pharmaceuticals
    • 8.2.2 3M
    • 8.2.3 AMD Lasers Inc
    • 8.2.4 ASA Dental S.p.A
    • 8.2.5 Biolase Inc
    • 8.2.6 Carl Martin GmbH
    • 8.2.7 Danaher
    • 8.2.8 Dentsply Sirona
    • 8.2.9 Deppeler SA
    • 8.2.10 Karl Schumacher
    • 8.2.11 Medtronic
    • 8.2.12 Novartis AG
    • 8.2.13 Pfizer Inc
    • 8.2.14 Planmeca Oy